The concentration-dependent inhibitory effect of the MITF inhibitor ML329 on glycolytic function in SK-mel-24 cells under high-glucose-concentration conditions observed in the present study clearly indicates that the activation of MITF is associated with the HIF-1α-mediated enhancement of glycolytic activity in some melanoma cells. The gene discussed is HIF1A; the disease is melanoma.